Bottom line
How much do PPH and MEDX overlap?
53% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 70.4% of PPH's assets and 59.3% of MEDX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings PPH and MEDX have in common
| Holding | % of PPH | % of MEDX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 20.23% | 18.46% | 18.46% |
| Novartis AG | 10.63% | 6.89% | 6.89% |
| Merck & Co Inc | 9.85% | 3.96% | 3.96% |
| AbbVie Inc | 4.57% | 8.85% | 4.57% |
| Pfizer Inc | 4.51% | 2.86% | 2.86% |
| Bristol-Myers Squibb Co | 4.47% | 4.42% | 4.42% |
| Gsk Plc | 4.42% | 2.71% | 2.71% |
| Johnson & Johnson | 4.35% | 5.59% | 4.35% |
| AstraZeneca PLC | 4.33% | 4.98% | 4.33% |
| Haleon PLC | 3.09% | 0.60% | 0.60% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PPH
- Novo Nordisk A/S — 5.37%
- McKesson Corp — 4.12%
- Sanofi SA — 4.00%
- Cencora Inc — 3.36%
- Teva Pharmaceutical Industries Ltd — 3.06%
- Takeda Pharmaceutical Co Ltd — 2.87%
- Zoetis Inc — 2.10%
- Viatris Inc — 1.10%
- Jazz Pharmaceuticals PLC — 1.08%
- Axsome Therapeutics Inc — 0.77%
- Corcept Therapeutics Inc — 0.50%
- Elanco Animal Health Inc — 0.35%
- State Street Global Advisors — 0.28%
- Organon & Co — 0.23%
- Bausch Health Cos Inc — 0.10%
Only in MEDX
- US Bank Mmda - Usbgfs 7 — 9.19%
- Alkermes PLC — 5.53%
- Ionis Pharmaceuticals Inc — 4.53%
- Amgen Inc — 3.91%
- Alnylam Pharmaceuticals Inc — 3.42%
- Biogen Inc — 3.09%
- CRISPR Therapeutics AG — 2.64%
- Regeneron Pharmaceuticals Inc — 2.06%
- Beam Therapeutics Inc — 1.51%
- Galectin Therapeutics Inc — 1.14%
- Intellia Therapeutics Inc — 1.12%
- Sandoz Group AG — 0.80%
- Replimune Group Inc — 0.73%
- Vanda Pharmaceuticals Inc — 0.73%
- Lantern Pharma Inc — 0.55%
Asset mix
| Asset type | PPH | MEDX |
|---|---|---|
| Stocks | 99.5% | 92.6% |
| Cash & short-term funds | 0.3% | 9.2% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | PPH | MEDX |
|---|---|---|
| US | 60.8% | 77.4% |
| GB | 11.8% | 8.6% |
| CH | 10.6% | 10.3% |
| IE | 1.1% | 5.5% |
| DK | 5.4% | — |
| FR | 4.0% | — |
| IL | 3.1% | — |
| JP | 2.9% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do PPH and MEDX overlap?
What stocks do PPH and MEDX have in common?
Should I own both PPH and MEDX?
Which holds more stocks, PPH or MEDX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.